Absci Corporation
ABSI
Rank in Stocks
#6179
Absci Corporation operates as a biopharmaceutical company primarily focused on... Absci Corporation operates as a biopharmaceutical company primarily focused on discovering novel drug targets and developing new therapeutic compounds. Leveraging its distinctive integrated drug creation platform, the firm generates potential biologic medicines and essential cell lines for manufacturing, which it provides to its collaborators, predominantly within the United States. This advanced platform is instrumental in facilitating the development of biologics by meticulously integrating the traditionally separate stages of drug discovery and cell line engineering into one streamlined process. Absci Corporation was founded in 2011 and is based in Vancouver, Washington.
Share Price
$10.80
Last synced: 2026-11-09
Market Cap
$1.85B
Change (1 day)
6.19%
Change (1 year)
213.04%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Absci Corporation (ABSI)
Category
Healthcare
Operating Margin for Absci Corporation (ABSI)
Operating Margin as of November 2026 TTM: -8,411.27%
According to Absci Corporation's latest financial reports, its current operating margin (TTM) is -8,411.27%. At the end of 2025 the company had an operating margin of -4,454.21%.
Operating Margin history for Absci Corporation from 2019 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -8,411.27% | 88.84% |
| 2025 | -4,454.21% | 85.47% |
| 2024 | -2,401.59% | 18.88% |
| 2023 | -2,020.20% | 8.76% |
| 2022 | -1,857.49% | 18.06% |
| 2021 | -1,573.36% | 465.43% |
| 2020 | -278.26% | -8.51% |
| 2019 | -304.13% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 38.59% | -100.00% |
US
|
|
| -149.01% | -99.98% |
US
|
|
| 25.57% | -100.00% |
AU
|
|
| 31.23% | -100.00% |
BE
|
|
| 29.35% | -100.00% |
NL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Absci Corporation's operating margin
What is Absci Corporation's operating margin?
Absci Corporation's operating margin is -8,411.27%, as of Nov 2026.
What was Absci Corporation's operating margin in 2025?
In 2025, Absci Corporation's operating margin was -4,454.21%, compared with -2,401.59% in 2024.
How has Absci Corporation's operating margin changed since 2020?
From 2020 to 2025, Absci Corporation's operating margin was highest in 2020 (-278.26%) and lowest in 2025 (-4,454.21%).
How does Absci Corporation's operating margin compare with similar companies?
Absci Corporation's operating margin (-8,411.27%) is lower than that of all 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 38.59%.